THE NEW HOPE FOR WEIGHT REGULATION?

Researchers are rapidly investigating retatrutide, a novel drug from Eli Lilly, as a possible advance in body loss . Different than many existing approaches, retatrutide is a dual -action compound targeting simultaneously GLP-1 and GIP, substances that affect appetite and glucose regulation . Pre